Page 39 - 《中国药科大学学报》2026年第1期

第 57 卷第 1 期 赵 磊，等：疟原虫组蛋白去乙酰化酶抑制剂研究进展 33

768. modial inhibitor targeting Plasmodium falciparum histone
[12] Andrews KT, Tran TN, Lucke AJ, et al. Potent antimalarial ac- deacetylase 1[J]. Cell Discov, 2020, 6(1): 93.
tivity of histone deacetylase inhibitor analogues[J]. Antimicrob [18] Meinke PT, Colletti SL, Doss G, et al. Synthesis of apicidin-de-
Agents Chemother, 2008, 52(4): 1454-1461. rived quinolone derivatives: parasite-selective histone deacety-
[13] Dow GS, Chen YF, Andrews KT, et al. Antimalarial activity of lase inhibitors and antiproliferative agents[J]. J Med Chem,
phenylthiazolyl-bearing hydroxamate-based histone deacety- 2000, 43(25): 4919-4922.
lase inhibitors[J]. Antimicrob Agents Chemother, 2008, 52(10): [19] Collins JE, Lee JW, Bohmer MJ, et al. Cyclic tetrapeptide
3467-3477. HDAC inhibitors with improved Plasmodium falciparum selec-
[14] Engel JA, Jones AJ, Avery VM, et al. Profiling the anti-proto- tivity and killing profile[J]. ACS Infect Dis, 2021, 7(10): 2889-
zoal activity of anti-cancer HDAC inhibitors against Plasmodi- 2903.
um and Trypanosoma parasites[J]. Int J Parasitol Drugs Drug [20] Ontoria JM, Paonessa G, Ponzi S, et al. Discovery of a selec-
Resist, 2015, 5(3): 117-126. tive series of inhibitors of Plasmodium falciparum HDACs[J].
[15] Giannini G, Battistuzzi G, Vignola D. Hydroxamic acid based ACS Med Chem Lett, 2016, 7(5): 454-459.
histone deacetylase inhibitors with confirmed activity against [21] Koumpoura CL, Robert A, Athanassopoulos CM, et al. Anti-
the malaria parasite[J]. Bioorg Med Chem Lett, 2015, 25(3): malarial inhibitors targeting epigenetics or mitochondria in
459-461. Plasmodium falciparum: recent survey upon synthesis and bio-
[16] Stenzel K, Chua MJ, Duffy S, et al. Design and synthesis of logical evaluation of potential drugs against malaria[J].
terephthalic acid-based histone deacetylase inhibitors with dual- Molecules, 2021, 26(18): 5711.
stage anti-Plasmodium activity[J]. ChemMedChem, 2017, [22] Potluri V, Shandil RK, Gavara R, et al. Discovery of FNDR-
12(19): 1627-1636. 20123, a histone deacetylase inhibitor for the treatment of Plas-
[17] Huang ZH, Li RX, Tang TK, et al. A novel multistage antiplas- modium falciparum malaria[J]. Malar J, 2020, 19(1): 365.